Total adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) activities were measured in cell samples from 13 cases of de novo acute leukemia and from three cases of chronic myeloid leukemia in blast crisis (CMLBC). These cases could be separated into lymphoid and nonlymphoid types on the basis of enzyme activity, with two misclassifications. However, PNP activity added little or no discriminatory information. Analysis for expression of the various molecular weight (mol wt) ADA isozymes, ADA1 (40 Kd) and ADA2 (110 Kd), revealed that ADA2 was expressed exclusively in nonlymphoid cells whereas ADA1 was found in both lymphoid and nonlymphoid cell types. Identification of ADA2 divided these leukemia cases into lymphoid and nonlymphoid types with no misclassifications (P = .0002; Fisher's exact test). Acute nonlymphoblastic leukemia (ANLL) with a monocytic component tended to have a greater percentage of ADA2 than ANLL without a monocytic component. These studies suggest that ADA2 may be a novel biochemical marker for an immature nonlymphoid cell.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Sclerosing angiomatoid nodular transformation (SANT) of the spleen: a case report.
Oxf Med Case Reports
December 2024
Department of Radiation Oncology, Bank of Cyprus Oncology Center, 32 Acropoleos Avenue, Nicosia 2011, Cyprus.
SANT is a rare, non-lymphoid, benign entity, originating from the red pulp of the spleen. It is characterized by the presence of vascular nodules surrounded by a stroma of collagen fibers. It was introduced as a distinct disease entity by Martel et al in 2004, after the histopathological examination of 25 cases.
View Article and Find Full Text PDFRegulation of intestinal tissue‑resident memory T cells: a potential target for inflammatory bowel disease.
Cell Commun Signal
December 2024
Department of Laboratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Tissue-resident memory T (TRM) cells are populations which settle down in non-lymphoid tissues instead of returning to secondary lymph organs after the antigen presentation. These cells can provide rapid on-site immune protection as well as long-term tissue damage. It is reported that TRM cells from small intestine and colon exhibited distinctive patterns of cytokine and granzyme expression along with substantial transcriptional and functional heterogeneity.
View Article and Find Full Text PDFGuidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DC.
Eur J Immunol
December 2024
Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
This article is part of the Dendritic Cell Guidelines article series, which provides a collection of state-of-the-art protocols for the preparation, phenotype analysis by flow cytometry, generation, fluorescence microscopy, and functional characterization of mouse and human dendritic cells (DC) from lymphoid organs, and various nonlymphoid tissues. Within this article, detailed protocols are presented that allow for the generation of single-cell suspensions from human nonlymphoid tissues including lung, skin, gingiva, intestine as well as from tumors and tumor-draining lymph nodes with a subsequent analysis of dendritic cells by flow cytometry. Further, prepared single-cell suspensions can be subjected to other applications including cellular enrichment procedures, RNA sequencing, functional assays, etc.
View Article and Find Full Text PDFFOXP3/TLS; a prognostic marker in patients with bladder carcinoma without muscle invasion.
Urol Oncol
December 2024
Mardin Training and Research Hospital, Pathology Laboratory, Mardin, Turkey. Electronic address:
Article Synopsis
- Bladder carcinoma (BC) is common, with 20% classified as non-muscle invasive bladder cancer (NMIBC), where about 40% of patients experience recurrence despite treatment.
- The study evaluates the prognostic implications of FOXP3, TIM-3, and tertiary lymphoid structures (TLS) in NMIBC by analyzing patient samples using immunohistochemistry and survival analysis.
- Findings indicate that higher levels of FOXP3/TLS correlate with better recurrence-free survival, suggesting that FOXP3/TLS may serve as an effective prognostic marker, especially for patients undergoing BCG treatment.
Maternal use of hormonal contraception and risk of childhood leukemia: A Scandinavian population-based cohort study.
Eur J Cancer
January 2025
Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark. Electronic address:
Background: Maternal hormonal contraception use has been associated with childhood leukemia risk. However, studies are few and often based on self-reported information.
Methods: Using registry data from Denmark, Norway, and Sweden, we identified 3,183,316 children (born 1996-2018) and followed them from birth until leukemia diagnosis, censoring (death, emigration, other cancer, 20th birthday) or study closure (December 31st, 2017, 2018 or 2020).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!